Medtronic Infuse Bone Graft Class Action

Schmidt & Clark, LLP is No Longer Taking These Cases - If you feel that you may have a potential case, we urge you to contact another law firm adequately suited to handle your case.

Recent studies have identified serious health risks associated with the Medtronic Infuse Bone Graft, a medical device used during spinal fusion surgery to promote bone growth. When implanted during unapproved or “off-label” procedures, the Infuse Spinal Fusion Graft has been reported to cause cancer, retrograde ejaculation, and neck or throat swelling. If you’ve been injured after being treated with the Infuse Graft, and are interested in filing a class action lawsuit against the manufacturer, our lawyers can help.

Infuse Bone Graft Complications

Allegedly, Medtronic Inc. neglected to warn the public and medical communities about severe health risks associated with its Infuse spinal fusion device. The company has also been accused of promoting the bone graft for unapproved or “off-label” purposes.

The U.S. Food & Drug Administration (FDA) approved the Infuse Bone Graft for lower spine surgery to stimulate bone growth, but it was not approved to treat the cervical spine. However, some doctors have used the device during cervical spine surgery to treat neck pain. Patients who were treated in this setting may be at risk for developing severe Infuse Bone Graft Complications including:

  • Cyst formation
  • Cancer
  • Infection
  • Infertility (sterility in men)
  • Retrograde ejaculation

Awards & recognition